PDCD1 and neoplasm: The stimulation of PD-1/PD-L1 on MDA-MB-231 and 4T1 tumor cells derives to doxorubicin resistance and on DU145 cells encounters docetaxel resistance, which would be followed by metastasis in all of these tumor cells.